Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Singulair for NARES
NCT00406094Phase 4Unknown
- Start
- Nov 2006
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Non-allergic rhinitis with eosinophilia syndrome (NARES) comparing Montelukast with Placebo (2 arms). Primary endpoints: Number of nasal eosinophils at 12 weeks and Nasal symptom scores at 12 weeks. Status: unknown.
02
Drugs
montelukast
03
Conditions
Non-allergic rhinitis with eosinophilia syndrome (NARES)
Beyond the preview
Go deeper on NCT00406094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406094.